These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7387851)

  • 21. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
    Workman P; Brown JM
    Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The penetration of misonidazole into a mature structural cartilage.
    Langler AJ; Bugden RD; Gibson P
    Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M; McNally NJ; Stratford MR
    Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J; Stratford MR
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
    Workman P
    Cancer Chemother Pharmacol; 1980; 5(1):27-37. PubMed ID: 7460192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
    Eifel PJ; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH; Urano M
    Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
    Lee FY; Workman P
    Cancer Chemother Pharmacol; 1986; 17(1):30-7. PubMed ID: 3698174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME; Monks A; Collins JM; White R; Strong JM
    J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ drug delivery.
    Levin VA; Wright DC; Landahl HD; Patlak CS; Csejtey J
    Br J Cancer Suppl; 1980 Apr; 4():74-8. PubMed ID: 6932949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
    Fujimoto S; Kobayashi K; Takahashi M; Konno C; Kokubun M; Ohta M; Shrestha RD; Kiuchi S
    Br J Cancer; 1992 Jan; 65(1):33-6. PubMed ID: 1733439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
    Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of misonidazole in the dog.
    White RA; Workman P; Freedman LS; Owen LN; Bleehen NM
    Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
    Conroy PJ; Von Burg R; Penney DP; Passalacqua W; Sutherland RM
    Br J Cancer; 1980 Apr; 41(4):523-8. PubMed ID: 7387850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.